Table 8.
Most frequent and the most serious adverse experiences by body system
| Body System | Side effect | Frequency |
|---|---|---|
| Hematologic | Thrombocymiddleenia | |
| GI | 37 (30.8%) | |
| GII | 13 (10.82%) | |
| GIII | 6 (4.9%) | |
| GIV | 5 (4.16%) | |
| Low Hb | ||
| GI | 78 (65%) | |
| GII | 20 (16.6%) | |
| GIII | 4 (3.33%) | |
| Low WBC | ||
| GI | 19 (15.8%) | |
| GII | 26 (21.6%) | |
| GIII | 1(0.83%) | |
| Hepatic | Bilirubin Elevation | |
| GI | 8 (6.6%) | |
| GII | 7 (5.83%) | |
| GIII | 3 (2.5%) | |
| Low Albumin | ||
| GI | 20 (16.6%) | |
| GII | 11 (9.16%) | |
| Renal | Serum Cr Elevation | |
| GI | 24 (20%) | |
| GII | 2 (1.66%) | |
| Gastrointestinal | Nausea | |
| G I | 144 (35.6%) | |
| G II | 54 (13.3%) | |
| Vomiting | ||
| G I | 40 (9.9%) | |
| G II | 14 (4.2%) | |
| Abdominal pain | 12 (2.9%) | |
| Skin | ||
| Flushing | 62 (15.3%) | |
| Others | ||
| Back pain | 10 (2.4%) | |
| Headache | 5 (1.23%) | |
| Pain in the site of injection | 3 (0.74%) |